Page last updated: 2024-09-04

moxifloxacin and levocetirizine

moxifloxacin has been researched along with levocetirizine in 3 studies

Compound Research Comparison

Studies (moxifloxacin)	Trials (moxifloxacin)	Recent Studies (post-2010) (moxifloxacin)	Studies (levocetirizine)	Trials (levocetirizine)	Recent Studies (post-2010) (levocetirizine)
3,157	552	1,690	296	110	122

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	2 (66.67)	2.80

Authors

Authors	Studies
Daoust, A; Hulhoven, R; Letiexhe, M; Meeus, MA; Rosillon, D; Stockis, A	1
Benson, C; Brown, R; Couderc, JP; Darpo, B; Dota, C; Ferber, G; Ferry, J; Jarugula, V; Keirns, J; Ortemann-Renon, C; Pham, T; Riley, S; Sarapa, N; Ticktin, M; Zareba, W	1
Baublits, J; Chandra, FA; Chui, RW; Engwall, MJ; Jones, ZW; Vargas, HM; Wahlstrom, J	1

Trials

2 trial(s) available for moxifloxacin and levocetirizine

Article	Year
Levocetirizine does not prolong the QT/QTc interval in healthy subjects: results from a thorough QT study. European journal of clinical pharmacology, 2007, Volume: 63, Issue:11 Topics: Adolescent; Adult; Aza Compounds; Cetirizine; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography, Ambulatory; Female; Fluoroquinolones; Heart Rate; Histamine H1 Antagonists, Non-Sedating; Humans; Long QT Syndrome; Male; Middle Aged; Moxifloxacin; Piperazines; Quinolines	2007
Evaluation of the Effect of 5 QT-Positive Drugs on the JTpeak Interval - An Analysis of ECGs From the IQ-CSRC Study. Journal of clinical pharmacology, 2020, Volume: 60, Issue:1 Topics: Arrhythmias, Cardiac; Biomarkers; Cetirizine; Drug-Related Side Effects and Adverse Reactions; Electrocardiography; Female; Fluoroquinolones; Healthy Volunteers; Heart Conduction System; Heart Rate; Humans; Indoles; Ion Channels; Long QT Syndrome; Male; Moxifloxacin; Ondansetron; Phenethylamines; Quinine; Quinolizines; Risk Assessment; Sulfonamides	2020

Article

Year

Levocetirizine does not prolong the QT/QTc interval in healthy subjects: results from a thorough QT study.

European journal of clinical pharmacology, 2007, Volume: 63, Issue:11

Topics: Adolescent; Adult; Aza Compounds; Cetirizine; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography, Ambulatory; Female; Fluoroquinolones; Heart Rate; Histamine H1 Antagonists, Non-Sedating; Humans; Long QT Syndrome; Male; Middle Aged; Moxifloxacin; Piperazines; Quinolines

2007

Evaluation of the Effect of 5 QT-Positive Drugs on the JTpeak Interval - An Analysis of ECGs From the IQ-CSRC Study.

Journal of clinical pharmacology, 2020, Volume: 60, Issue:1

Topics: Arrhythmias, Cardiac; Biomarkers; Cetirizine; Drug-Related Side Effects and Adverse Reactions; Electrocardiography; Female; Fluoroquinolones; Healthy Volunteers; Heart Conduction System; Heart Rate; Humans; Indoles; Ion Channels; Long QT Syndrome; Male; Moxifloxacin; Ondansetron; Phenethylamines; Quinine; Quinolizines; Risk Assessment; Sulfonamides

2020

Other Studies

1 other study(ies) available for moxifloxacin and levocetirizine

Article	Year
Evaluation of levocetirizine in beagle dog and cynomolgus monkey telemetry assays: Defining the no QTc effect profile by timepoint and concentration-QTc analysis. Clinical and translational science, 2023, Volume: 16, Issue:3 Topics: Animals; Dogs; Fluoroquinolones; Humans; Long QT Syndrome; Macaca fascicularis; Moxifloxacin; Telemetry	2023